ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,567Medicare Part D Prescriptions Filled, Including Refills

Rank: 264 out of 2343

$611K Total Retail Price of All Prescriptions

Rank: 460 out of 2343

457 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 457 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

8% of this provider’s 457 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 12,926 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
AMLODIPINE BESYLATE 812 788 1 5
SIMVASTATIN 774 725 2 1
LISINOPRIL 689 630 3 3
METOPROLOL TARTRATE 597 565 4 7
LEVOTHYROXINE SODIUM 458 454 5 2
WARFARIN SODIUM 371 361 6 8
METFORMIN HCL 366 360 7 9
HYDROCHLOROTHIAZIDE 333 326 8 11
CITALOPRAM HBR 329 303 9 17
FUROSEMIDE 323 315 10 6
OMEPRAZOLE 301 283 11 4
ATORVASTATIN CALCIUM 282 264 12 10
MIRTAZAPINE 213 209 13 41
ALENDRONATE SODIUM 202 195 14 28
FELODIPINE ER 199 195 15 116
PRAVASTATIN SODIUM 192 176 16 15
DIOVAN 188 188 17 23
ATENOLOL 183 171 18 12
HYDROCODONE-ACETAMINOPHEN 180 178 S3 19 13
TRAZODONE HCL 162 161 20 53
ENOXAPARIN SODIUM 135 113 21 203
FENTANYL 130 130 S2 22 69
DONEPEZIL HCL 128 126 23 21
METOPROLOL SUCCINATE 128 124 23 14
CLOPIDOGREL 125 113 25 26
CLONIDINE HCL 122 111 26 70
FAMOTIDINE 114 109 27 60
LOSARTAN POTASSIUM 112 111 28 19
CARVEDILOL 110 110 29 27
SERTRALINE HCL 108 101 30 20
GLIPIZIDE 108 108 30 56
CLOTRIMAZOLE-BETAMETHASONE 104 101 32 127
HUMULIN N 104 95 32 343
NAMENDA 99 95 34 36
ADVAIR DISKUS 97 97 35 34
TAMSULOSIN HCL 95 90 36 29
SYNTHROID 94 82 37 40
SEROQUEL 91 89 38 171
PANTOPRAZOLE SODIUM 89 89 39 22
ALBUTEROL SULFATE 87 86 40 126
PLAVIX 86 79 41 38
ALLOPURINOL 85 67 42 31
QUETIAPINE FUMARATE 84 78 43 77
VENTOLIN HFA 84 81 43 79
GABAPENTIN 80 73 45 16
DIOVAN HCT 74 74 46 63
INSULIN SYRINGE 74 67 46 102
EXFORGE 68 68 48 163
POTASSIUM CHLORIDE 64 64 49 18
PREDNISONE 64 64 49 37
LOVASTATIN 63 63 51 47
ISOSORBIDE MONONITRATE ER 63 63 51 32
KLOR-CON M20 62 60 53 44
FINASTERIDE 61 61 54 80
DIGOXIN 57 57 55 35
OXYCODONE HCL 55 55 S2 56 67
IBUPROFEN 51 42 57 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.